FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Juhani Eskola

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Geographic Areas

Finland

Anatomy

Bacterial Capsules

Procedures

Concepts & Ideas

Immunization Schedule

Co-author Network

Publications

TOP 3
Heidi J Larson; Louis Z Cooper; Juhani Eskola; Samuel L Katz; Scott Ratzan
Addressing the vaccine confidence gap.
Tomi Wuorimaa; Ron Dagan; Fabrice Bailleux; Raili Haikala; Nina Ekström; Juhani Eskola; Mansour Yaich; Helena Käyhty
Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine.
Ron Dagan; David Goldblatt; James R Maleckar; Mansour Yaïch; Juhani Eskola
Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Juhani Eskola (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Heidi J Larson; Louis Z Cooper; Juhani Eskola; Samuel L Katz; Scott Ratzan
Addressing the vaccine confidence gap.
Lancet 2011;378(9790):526-35.
2005: Tomi Wuorimaa; Ron Dagan; Fabrice Bailleux; Raili Haikala; Nina Ekström; Juhani Eskola; Mansour Yaich; Helena Käyhty
Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine.
Vaccine 2005;23(46-47):5328-32.
2004: Ron Dagan; David Goldblatt; James R Maleckar; Mansour Yaïch; Juhani Eskola
Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components.
Infection and immunity 2004;72(9):5383-91.
2004: Ron Dagan; Helena Kayhty; Tomi Wuorimaa; Mansour Yaich; Fabrice Bailleux; Orly Zamir; Juhani Eskola
Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
The Pediatric infectious disease journal 2004;23(2):91-8.
2003: P Helena Mäkelä; Helena Käyhty; Tuija Leino; Kari Auranen; Heikki Peltola; Nina Ekström; Juhani Eskola
Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine.
Vaccine 2003;22(2):287-92.
2003: Terhi Kilpi; Heidi Ahman; Jukka Jokinen; Kari Lankinen; Arto A I Palmu; Heljä Savolainen; Marko Grönholm; Maija Leinonen; Tapani Hovi; Juhani Eskola; Helena Käyhty; Norman Bohidar; Jerald C Sadoff; P Helena Mäkelä
Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(9):1155-64.
2002: Lauren O Bakaletz; Stephen J Barenkamp; Juhani Eskola; Bruce Green; Xin-Xing Gu; Teruhiko Harada; Terho Heikkinen; Pekka Karma; Jerome O Klein; Yuichi Kurono; Goro Mogi; Timothy F Murphy; Pearay L Ogra; Janak A Patel; Masashi Suzuki; Noboru Yamanaka
Recent advances in otitis media. 7. Vaccine.
The Annals of otology, rhinology & laryngology. Supplement 2002;188():82-94.
2001: Rose-Marie Olander; Tomi Wuorimaa; Helena Käyhty; Odile Leroy; Ron Dagan; Juhani Eskola
Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers.
Vaccine 2001;20(3-4):336-41.
2001: Tomi Wuorimaa; Ron Dagan; Merja Väkeväinen; Fabrice Bailleux; Raili Haikala; Mansour Yaich; Juhani Eskola; Helena Käyhty
Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
The Journal of infectious diseases 2001;184(9):1211-5.
2001: Anu Nurkka; Heidi Ahman; Mansour Yaich; Juhani Eskola; Helena Käyhty
Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.
Vaccine 2001;20(1-2):194-201.
2001: Merja Väkeväinen; C Eklund; Juhani Eskola; Helena Käyhty
Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
The Journal of infectious diseases 2001;184(6):789-93.
2001: Tomi Wuorimaa; Helena Käyhty; Juhani Eskola; Aini Bloigu; Odile Leroy; Heljä-Marja Surcel
Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine.
Scandinavian journal of immunology 2001;53(4):422-8.
2001: Tomi Wuorimaa; Ron Dagan; Juhani Eskola; J Janco; Heidi Ahman; Odile Leroy; Helena Käyhty
Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers.
The Pediatric infectious disease journal 2001;20(3):272-7.
2001: Tomi Wuorimaa; Helena Käyhty; Odile Leroy; Juhani Eskola
Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults.
Vaccine 2001;19(15-16):1863-9.
2001: Juhani Eskola; Terhi Kilpi; Arto A I Palmu; Jukka Jokinen; J Haapakoski; Elja Herva; Annika Takala; Helena Käyhty; Pekka Karma; Robert Kohberger; George R Siber; P Helena Mäkelä
Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
The New England journal of medicine 2001;344(6):403-9.
2001: Terttu Parkkali; Helena Käyhty; Hannu Lehtonen; Tapani Ruutu; Liisa Volin; Juhani Eskola; Petri Ruutu
Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients.
Bone marrow transplantation 2001;27(1):79-84.
2001: Anu Nurkka; Heidi Ahman; M Korkeila; Virva Jäntti; Helena Käyhty; Juhani Eskola
Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.
The Pediatric infectious disease journal 2001;20(1):25-33.
2000: Nancy P Hoe; Parichher Kordari; R Cole; Mengyao Liu; Timothy Palzkill; W Huang; D McLellan; Gerald J Adams; M Hu; Jaana Vuopio-Varkila; T R Cate; M E Pichichero; K M Edwards; Juhani Eskola; Donald E Low; James M Musser
Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics.
The Journal of infectious diseases 2000;182(5):1425-36.
2000: Juhani Eskola; T Kilpi
Potential of bacterial vaccines in the prevention of acute otitis media.
The Pediatric infectious disease journal 2000;19(5 Suppl):S72-8.
2000: Juhani Eskola
Immunogenicity of pneumococcal conjugate vaccines.
The Pediatric infectious disease journal 2000;19(4):388-93.
2000: M Korkeila; Hannu Lehtonen; Heidi Ahman; Odile Leroy; Juhani Eskola; Helena Käyhty
Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.
Vaccine 2000;18(13):1218-26.
1999: Juhani Eskola; J Ward; R Dagan; D Goldblatt; F Zepp; C A Siegrist
Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis.
Lancet 1999;354(9195):2063-8.
1999: M Anttila; M Voutilainen; Virva Jäntti; Juhani Eskola; Helena Käyhty
Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae.
Clinical and experimental immunology 1999;118(3):402-7.
1999: S Kalliola; Jaana Vuopio-Varkila; Annika Takala; Juhani Eskola
Neonatal group B streptococcal disease in Finland: a ten-year nationwide study.
The Pediatric infectious disease journal 1999;18(9):806-10.
1999: T Nieminen; Helena Käyhty; Odile Leroy; Juhani Eskola
Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.
The Pediatric infectious disease journal 1999;18(9):764-72.
1999: Heidi Ahman; Helena Käyhty; A Vuorela; Odile Leroy; Juhani Eskola
Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid.
Vaccine 1999;17(20-21):2726-32.
1999: Juhani Eskola; M Anttila
Pneumococcal conjugate vaccines.
The Pediatric infectious disease journal 1999;18(6):543-51.
1999: M Anttila; Juhani Eskola; Heidi Ahman; Helena Käyhty
Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood.
Vaccine 1999;17(15-16):1970-7.
1999: Anu Soininen; I Seppälä; T Nieminen; Juhani Eskola; Helena Käyhty
IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.
Vaccine 1999;17(15-16):1889-97.
1998: Juhani Eskola; Helena Käyhty
Early immunization with conjugate vaccines.
Vaccine 1998;16(14-15):1433-8.
1998: Juhani Eskola
Childhood immunisation today.
Drugs 1998;55(6):759-66.
1998: M Anttila; Juhani Eskola; Heidi Ahman; Helena Käyhty
Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
The Journal of infectious diseases 1998;177(6):1614-21.
1998: Ron Dagan; Juhani Eskola; C Leclerc; Odile Leroy
Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants.
Infection and immunity 1998;66(5):2093-8.
1998: T Nieminen; Juhani Eskola; Helena Käyhty
Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum.
Vaccine 1998;16(6):630-6.
1998: Heidi Ahman; Helena Käyhty; Hannu Lehtonen; Odile Leroy; J Froeschle; Juhani Eskola
Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.
The Pediatric infectious disease journal 1998;17(3):211-6.
1998: M Kauppi-Korkeila; Leena Saarinen; Juhani Eskola; Helena Käyhty
Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines.
Clinical and experimental immunology 1998;111(2):237-42.
1998: Juhani Eskola; Jukka Lumio; Jaana Vuopio-Varkila
Resurgent diphtheria--are we safe?
British medical bulletin 1998;54(3):635-45.
1998: Juhani Eskola; Annika Takala; Terhi Kilpi; Kari Lankinen; Helena Käyhty
Clinical evaluation of new pneumococcal vaccines: the Finnish approach.
Developments in biological standardization 1998;95():85-92.
1998: T Nieminen; Helena Käyhty; A Virolainen; Juhani Eskola
Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response.
Vaccine 1998;16(2-3):313-9.
1997: Terttu Parkkali; Rose-Marie Olander; Tapani Ruutu; K Vuontela; Liisa Volin; Juhani Eskola; Petri Ruutu
A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT.
Bone marrow transplantation 1997;19(9):933-8.
1997: Jussi Jero; A Virolainen; M Virtanen; Juhani Eskola; Pekka Karma
Prognosis of acute otitis media: factors associated with poor outcome.
Acta oto-laryngologica 1997;117(2):278-83.
1996: Juhani Eskola; Rose-Marie Olander; Tapani Hovi; L Litmanen; S Peltola; Helena Käyhty
Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
Lancet 1996;348(9043):1688-92.
1996: MR Capeding; Hanna Nohynek; L G Pascual; H Kayhty; Lydia T Sombrero; Juhani Eskola; Petri Ruutu
The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants.
The American journal of tropical medicine and hygiene 1996;55(5):516-20.
1996: Terttu Parkkali; Helena Käyhty; Tapani Ruutu; Liisa Volin; Juhani Eskola; Petri Ruutu
A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT.
Bone marrow transplantation 1996;18(5):961-7.
1996: Juhani Eskola
Analysis of Haemophilus influenzae type B conjugate and diphtheria-tetanus-pertussis combination vaccines.
The Journal of infectious diseases 1996;174 Suppl 3():S302-5.
1996: Helena Käyhty; Juhani Eskola
New vaccines for the prevention of pneumococcal infections.
Emerging infectious diseases 1996;2(4):289-98.
1996: S Kurikka; Rose-Marie Olander; Juhani Eskola; Helena Käyhty
Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy.
The Pediatric infectious disease journal 1996;15(6):530-5.
1996: S Kurikka; Helena Käyhty; L Saarinen; P Rönnberg; Juhani Eskola; P H Mäkelä
Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
The Journal of pediatrics 1996;128(4):524-30.
1996: Jussi Jero; A Virolainen; P Salo; Maija Leinonen; Juhani Eskola; Pekka Karma
PCR assay for detecting Streptococcus pneumoniae in the middle ear of children with otitis media with effusion.
Acta oto-laryngologica 1996;116(2):288-92.
1996: Heidi Ahman; Helena Käyhty; P Tamminen; A Vuorela; Frank J Malinoski; Juhani Eskola
Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.
The Pediatric infectious disease journal 1996;15(2):134-9.
1996: A Virolainen; Jussi Jero; P Chattopadhyay; Pekka Karma; Juhani Eskola; Maija Leinonen
Comparison of serum antibodies to pneumolysin with those to pneumococcal capsular polysaccharides in children with acute otitis media.
The Pediatric infectious disease journal 1996;15(2):128-33.
1996: Juhani Eskola; J Mertsola
[New vaccines against Bordetella Pertussis].
Duodecim; lääketieteellinen aikakauskirja 1996;112(13):1137-8.
1996: T Nieminen; A Virolainen; Helena Käyhty; Jussi Jero; Pekka Karma; Maija Leinonen; Juhani Eskola
Antibody-secreting cells and their relation to humoral antibodies in serum and in nasopharyngeal aspirates in children with pneumococcal acute otitis media.
The Journal of infectious diseases 1996;173(1):136-41.
1995: A Virolainen; Jussi Jero; Helena Käyhty; Pekka Karma; Maija Leinonen; Juhani Eskola
Antibodies to pneumolysin and pneumococcal capsular polysaccharides in middle ear fluid of children with acute otitis media.
Acta oto-laryngologica 1995;115(6):796-803.
1995: M Saarinen; Annika Takala; E Koskenniemi; E Kela; P R Rönnberg; E Pekkanen; P Kiiski; Juhani Eskola
Spectrum of 2,836 cases of invasive bacterial or fungal infections in children: results of prospective nationwide five-year surveillance in Finland. Finnish Pediatric Invasive Infection Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(5):1134-44.
1995: A Virolainen; Jussi Jero; Helena Käyhty; Pekka Karma; Juhani Eskola; Maija Leinonen
Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media.
Clinical and diagnostic laboratory immunology 1995;2(6):704-7.
1995: Helena Käyhty; Heidi Ahman; P R Rönnberg; R Tillikainen; Juhani Eskola
Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children.
The Journal of infectious diseases 1995;172(5):1273-8.
1995: S Kurikka; Helena Käyhty; L Saarinen; P R Rönnberg; Juhani Eskola; P H Mäkelä
Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy.
The Journal of infectious diseases 1995;172(5):1268-72.
1995: A Virolainen; Jussi Jero; Helena Käyhty; Pekka Karma; Maija Leinonen; Juhani Eskola
Nasopharyngeal antibodies to pneumococcal capsular polysaccharides in children with acute otitis media.
The Journal of infectious diseases 1995;172(4):1115-8.
1995: S Kurikka; Helena Käyhty; Heikki Peltola; L Saarinen; Juhani Eskola; P H Mäkelä
Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
Pediatrics 1995;95(6):815-22.
1995: H Nohynek; E Valkeila; Maija Leinonen; Juhani Eskola
Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children.
The Pediatric infectious disease journal 1995;14(6):484-90.
1995: Hanna Nohynek; Juhani Eskola; Marjaana Kleemola; E Jalonen; Pekka Saikku; Maija Leinonen
Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children.
The Pediatric infectious disease journal 1995;14(6):478-84.
1995: Juhani Eskola
Use of conjugate vaccines to prevent meningitis caused by Haemophilus influenzae type b or Streptococcus pneumoniae.
The Journal of hospital infection 1995;30 Suppl():313-21.
1995: M Kauppi; Juhani Eskola; Helena Käyhty
Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines.
The Pediatric infectious disease journal 1995;14(4):286-94.
1995: Annika Takala; J Jero; E Kela; P R Rönnberg; E Koskenniemi; Juhani Eskola
Risk factors for primary invasive pneumococcal disease among children in Finland.
JAMA : the journal of the American Medical Association 1995;273(11):859-64.
1994: A Virolainen; P Salo; Jussi Jero; Pekka Karma; Juhani Eskola; Maija Leinonen
Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media.
Journal of clinical microbiology 1994;32(11):2667-70.
1994: Heikki Peltola; Juhani Eskola; Helena Käyhty; Annika Takala; P H Mäkelä
Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy.
Archives of pediatrics & adolescent medicine 1994;148(6):620-5.
1994: Leila Unkila-Kallio; M J Kallio; Juhani Eskola; Heikki Peltola
Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children.
Pediatrics 1994;93(1):59-62.
1994: Juhani Eskola; Rose-Marie Olander; T Kuronen
[Reasons for diphtheria vaccination campaign].
Duodecim; lääketieteellinen aikakauskirja 1994;110(4):449.
1994: Annika Takala; E Koskenniemi; A Myllymäki; Juhani Eskola
[Realization of immunization in child health centers].
Duodecim; lääketieteellinen aikakauskirja 1994;110(19):1783-8.
1994: Juhani Eskola; Rose-Marie Olander; T Kuronen
[Is extensive diphtheria vaccination necessary?].
Duodecim; lääketieteellinen aikakauskirja 1994;110(1):11-2.
1993: Marjaana Kleemola; Tarja Heiskanen-Kosma; Hanna Nohynek; S Jokinen; Matti Korppi; Juhani Eskola
Diagnostic efficacy of a Mycoplasma pneumoniae hybridization test in nasopharyngeal aspirates of children.
The Pediatric infectious disease journal 1993;12(4):344-5.
1993: Annika Takala; O Meurman; Marjaana Kleemola; E Kela; P R Rönnberg; Juhani Eskola; P H Mäkelä
Preceding respiratory infection predisposing for primary and secondary invasive Haemophilus influenzae type b disease.
The Pediatric infectious disease journal 1993;12(3):189-95.
1993: Juhani Eskola; Annika Takala; H Käyhty
Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children.
Current opinion in pediatrics 1993;5(1):55-9.
1993: Juhani Eskola; Annika Takala; E Kela; E Pekkanen; R Kalliokoski; Maija Leinonen
[Serious pneumococcal diseases in children].
Duodecim; lääketieteellinen aikakauskirja 1993;109(14):1238-44.
1992: Juhani Eskola; Annika Takala; E Kela; E Pekkanen; R Kalliokoski; Maija Leinonen
Epidemiology of invasive pneumococcal infections in children in Finland.
JAMA : the journal of the American Medical Association 1992;268(23):3323-7.
1992: P H Mäkelä; Annika Takala; Heikki Peltola; Juhani Eskola
Epidemiology of invasive Haemophilus influenzae type b disease.
The Journal of infectious diseases 1992;165 Suppl 1():S2-6.
1992: Helena Käyhty; Juhani Eskola; Heikki Peltola; L Saarinen; P H Mäkelä
High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
The Journal of infectious diseases 1992;165 Suppl 1():S165-6.
1992: Juhani Eskola; Heikki Peltola; Helena Käyhty; Annika Takala; P H Mäkelä
Finnish efficacy trials with Haemophilus influenzae type b vaccines.
The Journal of infectious diseases 1992;165 Suppl 1():S137-8.
1992: Hanna Nohynek; Matti Korppi; Juhani Eskola
[Pneumonia in children].
Duodecim; lääketieteellinen aikakauskirja 1992;108(20):1810-8.
1991: Annika Takala; Juhani Eskola; Maija Leinonen; Helena Käyhty; A Nissinen; E Pekkanen; P H Mäkelä
Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.
The Journal of infectious diseases 1991;164(5):982-6.
1991: Juhani Eskola; Annika Takala; Helena Käyhty; Heikki Peltola; P H Mäkelä
Experience in Finland with Haemophilus influenzae type b vaccines.
Vaccine 1991;9 Suppl():S14-6; discussion S25.
1991: Hanna Nohynek; Juhani Eskola; E Laine; P Halonen; Petri Ruutu; Pekka Saikku; Marjaana Kleemola; Maija Leinonen
The causes of hospital-treated acute lower respiratory tract infection in children.
American journal of diseases of children (1960) 1991;145(6):618-22.
1991: Hanna Nohynek; A M Teppo; E Laine; Maija Leinonen; Juhani Eskola
Serum tumor necrosis factor-alpha concentrations in children hospitalized for acute lower respiratory tract infection.
The Journal of infectious diseases 1991;163(5):1029-32.
1991: Annika Takala; E Pekkanen; Juhani Eskola
Neonatal Haemophilus influenzae infections.
Archives of disease in childhood 1991;66(4 Spec No):437-40.
1991: Helena Käyhty; Juhani Eskola; Heikki Peltola; P R Rönnberg; E Kela; V Karanko; L Saarinen
Antibody responses to four Haemophilus influenzae type b conjugate vaccines.
American journal of diseases of children (1960) 1991;145(2):223-7.
1990: Annika Takala; Juhani Eskola; Loek van Alphen
Spectrum of invasive Haemophilus influenzae type b disease in adults.
Archives of internal medicine 1990;150(12):2573-6.
1990: Juhani Eskola; Helena Käyhty; Annika Takala; Heikki Peltola; P R Rönnberg; E Kela; E Pekkanen; P H McVerry; P H Mäkelä
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
The New England journal of medicine 1990;323(20):1381-7.
1990: P H Mäkelä; Juhani Eskola; Heikki Peltola; Annika Takala; Helena Käyhty
Clinical experience with Haemophilus influenzae type b conjugate vaccines.
Pediatrics 1990;85(4 Pt 2):651-3.
1990: Juhani Eskola; Helena Käyhty; Annika Takala; P R Rönnberg; E Kela; Heikki Peltola
Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children.
Vaccine 1990;8(2):107-10.
1989: Helena Käyhty; Heikki Peltola; Juhani Eskola; P R Rönnberg; E Kela; V Karanko; P H Mäkelä
Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age.
Pediatrics 1989;84(6):995-9.
1989: Annika Takala; Juhani Eskola; Juni Palmgren; P R Rönnberg; E Kela; P Rekola; P H Mäkelä
Risk factors of invasive Haemophilus influenzae type b disease among children in Finland.
The Journal of pediatrics 1989;115(5 Pt 1):694-701.
1989: Annika Takala; P R Rönnberg; E Kela; Juhani Eskola; M Mäkelä
Increased risk of primary invasive Haemophilus influenzae type B disease in twins.
The Pediatric infectious disease journal 1989;8(11):799-800.
1989: Annika Takala; Loek van Alphen; J M Musser; L Geelen; R K Selander; Juhani Eskola; P H Mäkelä
Bacteriologic epidemiology of Hemophilus influenzae type b strains causing invasive infections in Finland.
The Journal of infectious diseases 1989;160(2):237-42.
1989: Annika Takala; Juhani Eskola; Heikki Peltola; P H Mäkelä
Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine.
The Pediatric infectious disease journal 1989;8(5):297-302.
1989: P H Mäkelä; Helena Käyhty; Heikki Peltola; Juhani Eskola
Vaccines for Haemophilus influenzae type b as models for an otitis vaccine.
The Pediatric infectious disease journal 1989;8(1 Suppl):S73-5.
1989: Helena Käyhty; Jan Poolman; H Abdillahi; A Sivonen; Juhani Eskola; E Tarkka; Heikki Peltola
Sero- and subtypes of group B meningococci causing invasive infections in Finland in 1976-87.
Scandinavian journal of infectious diseases 1989;21(5):527-35.
1988: Helena Käyhty; O Mäkelä; Juhani Eskola; L Saarinen; I Seppälä
Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18-24 months of age.
The Journal of infectious diseases 1988;158(5):973-82.
1988: I Seppälä; H Sarvas; O Mäkelä; P Mattila; Juhani Eskola; Helena Käyhty
Human antibody responses to two conjugate vaccines of Haemophilus influenzae type B saccharides and diphtheria toxin.
Scandinavian journal of immunology 1988;28(4):471-9.
1988: T K Klemola; Juhani Eskola; Erkki Savilahti
T- and B-cell functions in IgA-deficient patients.
Scandinavian journal of immunology 1988;28(3):301-6.
1988: Helena Käyhty; Heikki Peltola; Juhani Eskola
Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
The Pediatric infectious disease journal 1988;7(8):574-7.
1988: Juhani Eskola; Helena Käyhty; L K Gordon; Tapani Hovi; M Stenvik; P R Rönnberg; E Kela; Heikki Peltola
Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood.
The Pediatric infectious disease journal 1988;7(7):480-4.
1987: Annika Takala; L van Alphen; Juhani Eskola; Juni Palmgren; P Bol; P H Mäkelä
Haemophilus influenzae type b strains of outer membrane subtypes 1 and 1c cause different types of invasive disease.
Lancet 1987;2(8560):647-50.
1987: Juhani Eskola; Heikki Peltola; Annika Takala; Helena Käyhty; M Hakulinen; V Karanko; E Kela; P Rekola; P R Rönnberg; J S Samuelson
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
The New England journal of medicine 1987;317(12):717-22.
1987: O Mäkelä; P Mattila; Nina Rautonen; I Seppälä; Juhani Eskola; Helena Käyhty
Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid).
Journal of immunology (Baltimore, Md. : 1950) 1987;139(6):1999-2004.
1987: Juhani Eskola; A Takala; Helena Käyhty; M Leinonen; Terhi Kilpi; Heikki Peltola; P H Mäkelä
Secondary cases of invasive disease caused by spread of Haemophilus influenzae type b.
The Journal of infection 1987;14(3):233-6.
1986: Juhani Eskola; A Takala; Helena Käyhty; M Leinonen; Terhi Kilpi; Heikki Peltola; P H Mäkelä
[Severe Haemophilus influenzae infections in children are contagious].
Duodecim; lääketieteellinen aikakauskirja 1986;102(15):1040-3.
1985: Juhani Eskola; Helena Käyhty; Heikki Peltola; V Karanko; P H Mäkelä; J Samuelson; L K Gordon
Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine.
Lancet 1985;1(8439):1184-6.